Concurrent gene editing and reprogramming of sickle cell disease fibroblasts using dual measles virus vectors

Grant Project Details:

Patricia Devaux, PhD
Mayo Clinic | Rochester, MN
In Process
Explore all RMM grants awarded since inception

Grant timeline: proposal, updates, reports

Grant Location

Mayo Clinic
200 First St
Rochester, MN 55905

Grant Description

We have developed a new technology to reprogram human cells to go back to a state from which they can then develop into other kinds of cells. Our technology is based on a strain of Measles virus, one of the safest vaccines in human history. In this project we will use modify our technology to correct genetic mutation in the human genome and particularly in patients with inherited red blood cell disorders, such as sickle cell disease.

Grant Awardee Biography

image of Patricia Devaux, PhD